X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1784) 1784
Publication (218) 218
Book Review (17) 17
Book Chapter (14) 14
Book / eBook (6) 6
Conference Proceeding (3) 3
Dissertation (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1280) 1280
infant, newborn (1110) 1110
index medicus (967) 967
pediatrics (847) 847
female (824) 824
infants (664) 664
male (568) 568
sepsis (541) 541
late-onset sepsis (525) 525
risk factors (444) 444
pregnancy (361) 361
birth-weight infants (354) 354
obstetrics & gynecology (327) 327
infection (308) 308
infectious diseases (301) 301
infant, premature (271) 271
infections (270) 270
prevention (270) 270
early-onset sepsis (265) 265
neonatal sepsis (265) 265
health aspects (262) 262
infant (262) 262
retrospective studies (243) 243
risk-factors (232) 232
anti-bacterial agents - therapeutic use (230) 230
mortality (216) 216
antibiotics (210) 210
diagnosis (210) 210
incidence (208) 208
preterm infants (204) 204
age of onset (198) 198
intensive care units, neonatal (197) 197
intensive-care-unit (196) 196
c-reactive protein (192) 192
neonates (184) 184
disease (183) 183
gestational age (181) 181
prospective studies (180) 180
sepsis - microbiology (177) 177
immunology (175) 175
group b streptococcus (171) 171
adult (170) 170
research (170) 170
sepsis - diagnosis (169) 169
sepsis - epidemiology (166) 166
infant, very low birth weight (163) 163
epidemiology (162) 162
necrotizing enterocolitis (151) 151
abridged index medicus (148) 148
onset neonatal sepsis (143) 143
streptococcus agalactiae (142) 142
newborn (141) 141
birth weight (140) 140
colonization (130) 130
microbiology (130) 130
article (128) 128
analysis (127) 127
children (126) 126
onset sepsis (125) 125
cohort studies (120) 120
research network (117) 117
streptococcal infections - prevention & control (114) 114
nosocomial infections (113) 113
risk (113) 113
care and treatment (112) 112
blood-stream infections (110) 110
neonate (110) 110
treatment outcome (108) 108
bacteremia (105) 105
medicine, general & internal (104) 104
management (101) 101
sepsis - prevention & control (100) 100
streptococcal infections - epidemiology (98) 98
age (97) 97
sepsis - drug therapy (97) 97
babies (93) 93
diseases (90) 90
biomarkers - blood (88) 88
blood (88) 88
medicine (88) 88
chorioamnionitis (85) 85
newborn babies (85) 85
premature-infants (85) 85
time factors (85) 85
sepsis - blood (84) 84
case-control studies (83) 83
procalcitonin (82) 82
antibiotic prophylaxis (81) 81
prophylaxis (81) 81
cross infection - epidemiology (80) 80
streptococcus agalactiae - isolation & purification (80) 80
bacteria (79) 79
meningitis (79) 79
research article (78) 78
surveillance (78) 78
infant, premature, diseases - epidemiology (76) 76
inflammation (76) 76
original article (75) 75
streptococcal infections - microbiology (72) 72
child (71) 71
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Providence Healthcare - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1708) 1708
Spanish (50) 50
French (26) 26
German (7) 7
Portuguese (5) 5
Korean (2) 2
Turkish (2) 2
Catalan (1) 1
Croatian (1) 1
Hebrew (1) 1
Italian (1) 1
Lithuanian (1) 1
Polish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10104, pp. 1770 - 1780
Summary Neonatal sepsis is the cause of substantial morbidity and mortality. Precise estimates of neonatal sepsis burden vary by setting. Differing estimates... 
Internal Medicine | UNITED-STATES | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | CANDIDA-PARAPSILOSIS | INFECTIONS | MANAGEMENT | COLONY-STIMULATING FACTOR | EARLY-ONSET SEPSIS | RISK | PRETERM NEWBORNS | TERM | Prenatal Exposure Delayed Effects | Chorioamnionitis | Humans | Risk Factors | Neonatal Sepsis - diagnosis | Anti-Infective Agents - therapeutic use | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Cross Infection - complications | Cross Infection - drug therapy | Pentoxifylline - therapeutic use | Blood Component Transfusion | Pregnancy | Neonatal Sepsis - therapy | Algorithms | Granulocytes | Immunoglobulins, Intravenous - therapeutic use | Neonatal Sepsis - etiology | Female | Free Radical Scavengers - therapeutic use | Neonatal Sepsis - epidemiology | Infant, Newborn | Infants (Newborn) | Cross infection | Nosocomial infections | Medical colleges | Medical research | Communicable diseases | Mortality | Medicine, Experimental | Plants | Children | Health aspects | Diseases | Neonates | Pediatrics | Pathogens | Intensive care | Subclinical infection | Bacterial infections | Virulence | Health risks | Infections | Infants | Immune status | Vaccines | Morbidity | Immunology | Newborn babies | Sepsis | Bacteria | Age | Inoculum | Laboratories | Neutrophils | Income | Glucose | Epidemiology | Flora | Meningitis
Journal Article
Paediatrics and Child Health, ISSN 1751-7222, 06/2019, Volume 29, Issue 6, pp. 263 - 268
Neonatal sepsis is a cause of significant mortality and morbidity. It can be early (less than 72 h) or late onset (more than 72 h age). Group B Streptococcus... 
late onset sepsis | group B streptococcus | early onset sepsis | neonatal sepsis | Infants (Newborn) | Sepsis | Care and treatment | Diagnosis | Risk factors | Diseases
Journal Article
Current Opinion in Pediatrics, ISSN 1040-8703, 04/2016, Volume 28, Issue 2, pp. 135 - 140
Journal Article
Journal of Infection, ISSN 0163-4453, 2013, Volume 68, Issue 1, pp. S24 - S32
Summary Neonates are predisposed to infections during the perinatal period due to multiple exposures and a relatively compromised immune system. The burden of... 
Infectious Disease | Prevention | Burden | Management | Neonatal sepsis | INFECTIOUS DISEASES | BLOOD-STREAM INFECTION | LATE-ONSET SEPSIS | FLUCONAZOLE PROPHYLAXIS | PRETERM INFANTS | RANDOMIZED CONTROLLED-TRIAL | MORTALITY-RATES | BIRTH-WEIGHT INFANTS | INTENSIVE-CARE-UNIT | INVASIVE CANDIDA INFECTIONS | B-STREPTOCOCCAL DISEASE | Humans | Gram-Positive Bacterial Infections - mortality | Sepsis - diagnosis | Candidemia - mortality | Organizational Policy | Infection Control - methods | Antifungal Agents - therapeutic use | Anti-Bacterial Agents - therapeutic use | Health Policy | Infant, Newborn | Global Health | Risk Factors | Sepsis - epidemiology | Antibiotic Prophylaxis - methods | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Gram-Positive Bacterial Infections - diagnosis | Candidemia - epidemiology | Candidemia - diagnosis | Gram-Positive Bacterial Infections - epidemiology | Sepsis - mortality | Candidemia - drug therapy | Sepsis - therapy | Survival Analysis | Gram-Negative Bacterial Infections - epidemiology | Gram-Negative Bacterial Infections - diagnosis | Gram-Positive Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Infants (Newborn) | Fluconazole | Patient outcomes | Mycoses | Development and progression | Cross infection | Infants | Nosocomial infections | Indexing in process
Journal Article
Pediatrics, ISSN 0031-4005, 12/2016, Volume 138, Issue 6, pp. e20162013 - e20162013
Journal Article
Pediatric Clinics of North America, ISSN 0031-3955, 04/2013, Volume 60, Issue 2, pp. 367 - 389
Neonatal sepsis remains a feared cause of morbidity and mortality in the neonatal period. Maternal, neonatal, and environmental factors are associated with... 
Biologic markers | Treatment | Early and late onset disease | Immature immunity | Neonatal sepsis | C-REACTIVE PROTEIN | STAPHYLOCOCCUS-AUREUS BACTEREMIA | INTRAPARTUM ANTIBIOTIC-PROPHYLAXIS | TOTAL PARENTERAL-NUTRITION | BIRTH-WEIGHT INFANTS | INTENSIVE-CARE-UNIT | EARLY-ONSET SEPSIS | INTRAVENOUS IMMUNE GLOBULIN | B STREPTOCOCCAL DISEASE | PEDIATRICS | OF-THE-LITERATURE | Predictive Value of Tests | Streptococcus agalactiae - immunology | Infant, Newborn, Diseases - epidemiology | Sepsis - prevention & control | Genomics | Humans | Fluconazole - administration & dosage | Immunoglobulins, Intravenous - administration & dosage | Infant, Newborn, Diseases - microbiology | Lactoferrin - administration & dosage | Infant, Newborn, Diseases - drug therapy | Streptococcus agalactiae - isolation & purification | Bacterial Infections - complications | Sepsis - drug therapy | C-Reactive Protein - metabolism | Polymerase Chain Reaction | Infant, Newborn | Infant, Newborn, Diseases - immunology | Adaptive Immunity | Sepsis - immunology | Risk Factors | Sepsis - epidemiology | Biomarkers - blood | Immunity, Innate | Candidiasis - complications | Blood Cell Count | Infant, Newborn, Diseases - blood | Anti-Infective Agents - administration & dosage | Antibodies, Monoclonal - administration & dosage | Proteomics | Escherichia coli Infections - immunology | Sepsis - blood | Streptococcal Infections - complications | Streptococcal Infections - immunology | Antifungal Agents - administration & dosage | Escherichia coli Infections - complications | Sepsis - microbiology
Journal Article
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, ISSN 1359-2998, 11/2012, Volume 97, Issue 6, pp. F456 - F462
Background Neonatal sepsis due to intestinal bacterial translocation is a major cause of morbidity and mortality. Understanding microbial colonisation of the... 
TRANSLOCATION | EMPIRICAL ANTIBIOTIC-TREATMENT | INTESTINAL MICROBIOTA | CHRONIC INFLAMMATORY DISORDERS | PEDIATRICS | PRETERM INFANTS | INFECTION | 99TH DAHLEM CONFERENCE | ONSET SEPSIS | NEWBORNS | DURATION
Journal Article
Paediatrics and Child Health, ISSN 1751-7222, 2015, Volume 25, Issue 6, pp. 271 - 275
Journal Article
Pediatrics, ISSN 0031-4005, 05/2011, Volume 127, Issue 5, pp. 817 - 826
BACKGROUND: Guidelines for prevention of group B streptococcal (GBS) infection have successfully reduced early onset (EO) GBS disease. Study results suggest... 
Group B streptococcal disease | Escherichia coli infection | Neonatal sepsis | INFECTIONS | ESCHERICHIA-COLI | PATTERNS | PRETERM INFANTS | INTRAPARTUM ANTIBIOTIC-PROPHYLAXIS | MENINGITIS | BIRTH-WEIGHT INFANTS | group B streptococcal disease | INTENSIVE-CARE-UNIT | ERA | RESISTANCE | PEDIATRICS | neonatal sepsis | Follow-Up Studies | Escherichia coli Infections - prevention & control | United States | Humans | Male | Streptococcal Infections - prevention & control | Incidence | Streptococcus agalactiae - isolation & purification | Anti-Bacterial Agents - therapeutic use | Bacteremia - prevention & control | Female | Registries | Retrospective Studies | Primary Prevention - organization & administration | Infant, Newborn | Escherichia coli Infections - drug therapy | Risk Assessment | Bacteremia - drug therapy | Streptococcal Infections - epidemiology | Escherichia coli Infections - epidemiology | Escherichia coli - isolation & purification | Infant, Premature | Age of Onset | Survival Analysis | Bacteremia - epidemiology | Streptococcal Infections - drug therapy | Neonatal Screening - organization & administration | Prevention | Sepsis | Streptococcal infections | Escherichia coli infections | Research | Demographic aspects | Babies | Pediatrics | Bacterial infections | E coli | Maternal & child health | Premature birth
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 11/2011, Volume 30, Issue 11, pp. 937 - 941
BACKGROUND:Sepsis in the first 3 days of life is a leading cause of morbidity and mortality among infants. Group B Streptococcus (GBS), historically the... 
group B Streptococcus | neonatal sepsis | disease burden | early-onset | INFECTIOUS DISEASES | INFECTIONS | RISK-FACTORS | PREVENTION | IMMUNOLOGY | NATIONAL INSTITUTE | CHILD HEALTH | INFANTS | B-STREPTOCOCCAL DISEASE | PEDIATRICS | United States - epidemiology | Streptococcus agalactiae - drug effects | Streptococcus agalactiae - pathogenicity | Streptococcus agalactiae - physiology | African Continental Ancestry Group - ethnology | Humans | Infant | Male | Antibiotic Prophylaxis | Infant, Premature, Diseases - mortality | Streptococcal Infections - prevention & control | Streptococcal Infections - mortality | Incidence | Anti-Bacterial Agents - therapeutic use | Infant, Premature, Diseases - ethnology | Pregnancy Complications, Infectious - prevention & control | Female | Retrospective Studies | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Streptococcal Infections - microbiology | Infant, Premature, Diseases - prevention & control | Infant, Premature, Diseases - microbiology | Pregnancy Complications, Infectious - ethnology | Survival Rate | Infant, Premature, Diseases - drug therapy | Pregnancy | Streptococcal Infections - ethnology | Infant, Premature | Pregnancy Complications, Infectious - drug therapy | Sepsis | Streptococcal Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Population Surveillance
Journal Article